Management for R&D in Pharmaceutical Supply Chains

被引：0

作者：

Huang Yin ^{[1
]}

Li Xiamiao ^{[1
]}

Liu Dapeng ^{[1
]}

机构：

[1] Cent S Univ, Sch Transportat & Traff Engn, Changsha, Hunan, Peoples R China

来源：

MOT2009: PROCEEDINGS OF ZHENGZHOU CONFERENCE ON MANAGEMENT OF TECHNOLOGY, VOLS I AND II | 2009年

关键词：

Supply chains; pharmaceutical industries; management; REAL OPTIONS; MODELING FRAMEWORK; RISK-MANAGEMENT; OPTIMIZATION; UNCERTAINTY; PORTFOLIOS; PLANTS;

D O I：

暂无

中图分类号：

TP [自动化技术、计算机技术];

学科分类号：

0812 ;

摘要：

Over the last few years, management for R&D in pharmaceutical supply chain. Pharmaceutical products differ somewhat from other products. For this reason, a great deal of the recent research has focused on the research and development(R&D) projects. This article reviews the current literature on supply chain management for pharmaceutical products. The review discusses some interesting open research questions in this field, and points out new directions for future research.

引用

页码：638 / 644

页数：7

共 50 条

[21] The productivity crisis in pharmaceutical R&D
Fabio Pammolli
Laura Magazzini
Massimo Riccaboni
[J]. Nature Reviews Drug Discovery, 2011, 10 : 428 - 438
[22] Will genomics revolutionise pharmaceutical R&D?
Noble, D
[J]. TRENDS IN BIOTECHNOLOGY, 2003, 21 (08) : 333 - 337
[23] Pharmaceutical R&D and the chemical engineer
Stracey, J
[J]. TCE, 2002, (732): : 36 - 37
[24] Applications of lipidomics in pharmaceutical R&D
Ekroos, Kim
[J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (01) : S22 - S23
[25] Pharmaceutical R&D: an age of change?
Baldwin, John J.
[J]. FUTURE MEDICINAL CHEMISTRY, 2014, 6 (10) : 1109 - 1112
[26] MANAGING RISK IN PHARMACEUTICAL R&D
Case, Randolph H.
[J]. RESEARCH-TECHNOLOGY MANAGEMENT, 2010, 53 (02) : 24 - 32
[27] R&D in the Global Pharmaceutical Markets
Kermani, Faiz
Wollowitz, Susan
[J]. FUTURE OF THE CHEMICAL INDUSTRY, 2009, 1026 : 19 - 45
[28] The changing shape of pharmaceutical R&D
Nicolaides, D
[J]. CHEMICAL INNOVATION, 2001, 31 (11): : 40 - 46
[29] The impact of mergers on pharmaceutical R&D
LaMattina, John L.
[J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (08) : 559 - 560
[30] The limits to upgrading and value capture in R&D global value chains: Indian and Chinese contract R&D firms in the integrated circuit design and pharmaceutical global value chains
Fuller, Douglas B.
Ramirez, Paulina
[J]. COMPETITION & CHANGE, 2024, 28 (01) : 144 - 164

← 1 2 3 4 5 →